Weekly Roundup
Oct 2, 2026
•
4 min read
AI can now leave its signature inside biology.
Sep 25, 2026
Better tools can still narrow thinking.
Sep 18, 2026
3 min read
AI may let pharma share the value of its secrets without ever sharing the secrets themselves.
Sep 11, 2026
AlphaGenome opens billions of possibilities. Drug discovery may still crowd into the safest ones.
Sep 4, 2026
South Korea’s K-Fold is an early glimpse of what sovereign medicine could look like.
Aug 28, 2026
Instead, better models may be making Big Pharma’s decades of failed experiments more valuable.
Aug 21, 2026
Just not the jobs people expect.
Aug 14, 2026
Formation Bio’s unusual AI strategy starts with an idea about where drug discovery is heading.
Aug 7, 2026
Inside Pathos AI’s plan to search for clinical assets, acquire them and apply a repeatable development system.
